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Introduction
Procedural sedation and analgesia are routinely provided to
pediatric patients requiring painful procedures. In this
context, propofol has gained popularity because of its rapid
induction of deep sedation and brief duration of action.
Propofol is thought to produce its sedative/anesthetic effects
by the positive modulation of the inhibitory function of the
neurotransmitter γ-aminobutyric acid (GABA) through
the ligand-gated GABAA receptors. The onset of sedation is
within 40 seconds and a single dose of propofol typically
wears off within minutes.1–4 Limitations of propofol include
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Abstract Objective Examine comparative dosing, efﬁcacy, and safety of propofol alone or with
an initial, subdissociative dose of ketamine approach for deep sedation.
Background Propofol is a sedative-hypnotic agent used increasingly in children for
deep sedation. As a nonanalgesic agent, use in procedures (e.g., bone marrow biopsies/
aspirations, renal biopsies) is debated. Our intensivist procedural sedation team sedates
using one of two protocols: propofol-only (P-O) approach or age-adjusted dose of 0.25
or 0.5 mg/kg intravenous ketamine (K þ P) prior to propofol. With either approach, an
initial induction dose of 1 mg/kg propofol is recommended and then intermittent
dosing throughout the procedure to achieve adequate sedation to safely and effectively
perform the procedure. Approach: Retrospective evaluation of 754 patients receiving
either the P-O or K þ P approach to sedation.
Results A total of 372 P-O group patients and 382 K þ P group. Mean age (7.3  5.5
years for P-O; 7.3  5.4 years for K þ P) and weight (30.09  23.18 kg for P-O;
30.14  24.45 kg for K þ P) were similar in both groups (p ¼ NS). All patients
successfully completed procedures with a 16% combined incidence of hypoxia (SPO2
< 90%). Procedure time was 3 minutes longer for K þ P group than P-O group
(18.68  15.13 minutes for K þ P; 15.11  12.77 minutes for P-O; p < 0.01), yet
recovery times were 5 minutes shorter (17.04  9.36 minutes for K þ P;
22.17  12.84minutes for P-O; p < 0.01). Mean total dose of propofol was signiﬁcantly
greater in P-O than in K þ P group (0.28  0.20mg/kg/min for K þ P; 0.40  0.26mg/
kg/min for P-O; p < 0.0001), and might explain the shorter recovery time.
Conclusion Both sedation approaches proved to be well tolerated and equally
effective. Addition of ketamine was associated with reduction in the recovery time,
probably explained by the statistically signiﬁcant decrease in the propofol dose.
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pain at the injection site, as well as respiratory and hemody-
namic instability. Because propofol lacks intrinsic analgesic
properties, opioids may be co-administered during the
procedures, which may add to the risk of cardiac and
respiratory depression.3,5–8 Ketamine is a unique sedative
resulting in a lack of patient response to any stimuli caused by
dissociation between the thalamic and limbic regions of the
brain. This dissociative sedation resembles a trancelike
cataleptic state with profound sedation, analgesia, and
amnesia due to its action on N-methyl-D-aspartate
(NMDA) and non-NMDA glutamate receptors, nicotinic and
muscarinic cholinergic, and monoaminergic and opioid
receptors. Its onset of action is within a few minutes of
administration with an elimination half-life of 7 to 11
minutes.9–11
Ketamine preserves respiratory drive and maintains pro-
tective airway reﬂexes with minimal cardiovascular depres-
sion due to sympathomimetic properties.10,11 Major side
effects of ketamine are the incidence of emergent reactions
at increasing doses, such as hallucination, nightmares, and
excessive salivation in certain patients.10,11
Several synergies are apparent between these two agents. As
a result, this combination is being increasingly used due to
perceived advantages over propofol only for procedural sedation
but few known direct comparisons exist. Our intensivist-led
sedation team used a propofol-only protocol from 2006 to 2010
for all painful and nonpainful procedures.
In 2011, our group transitioned to the use of low-dose
ketamine with propofol for all procedures. We hypothesized
that the use of this combination is a safe and effective
alternative, with the potential of less propofol requirements
resulting in shorter recovery times.
Materials and Methods
Collection of quality assurance data includes: patient demo-
graphics, adverse events, physiologic variables, drug dosages,
time required to sedate the patient, time needed to complete
the procedure, and recovery time. After approval by the
institutional review board, we conducted a retrospective
analysis using the above-mentioned database of all patients
who received deep sedation for procedures between October,
2010, and May, 2012.
Institutional sedation policies, based on guidelines devel-
oped by the Joint Commission on Accreditation of Health Care
Organization and the American Academy of Pediatrics, were
closely followed.12,13 All patients were screened tomake sure
that they were appropriate sedation candidates (e.g., ASA I
and III) and age 6 months to 18 years. The screening process
includes a chart review, pastmedical history, and surgical and
anesthetic histories. Patients were excluded from the study
for: age < 6 months or > 18; ASA classiﬁcation IV or greater;
history of signiﬁcant active cardiac, pulmonary, hepatic, or
renal disease;weight > 130 kg; history of diagnosed obstruc-
tive sleep apnea; or history of allergy or sensitivity to any
sedation medication. Parents are contacted directly by
telephone to resolve any unclear medical issues. Vital
signs including pulse oximetry, heart rate, noninvasive blood
pressure monitoring, and nasal capnography were
continuously monitored and documented every 5 minutes
throughout sedation.
The propofol-only (P-O) sedation protocol consisted of an
intravenous (IV) bolus of propofol 1 mg/kg over 1 to 2
minutes. Repeat boluses were used as needed to achieve
andmaintain the desired level of sedation until the procedure
was over. In the ketamine þ propofol (K þ P) group, sedation
was started with a single low dose of ketamine bolus (0.5/kg
mg < 20 kg; 0.25/kg mg > 20 kg) followed with IV propofol
titrated as above. The reason for choosing low dose in heavy
weight and older patient was to avoid giving them higher
cumulative doses and to avoid the side effects of emergence
reaction and excessive salivation.
There was no maximum dose of propofol as long as the
patient’s respiratory and hemodynamic status remained
stable. Supplemental oxygen was administered via nasal
cannula if saturation dropped to less than 90% for more
than 30 seconds. Peak onset of the sedation is the time
from the start of the loading dose to achievement of a Ramsay
score of 4. Procedure time is deﬁned as the time from
achieving the required Ramsay score to the end of the
procedure (stoppage of drug administration). Recovery time
was deﬁned as the time from the end of the procedure to
actual time the patient was back to baseline status. Discharge
time is the time from recovery until the discharge of the child
from the recovery room.
Data are presented as means and standard deviations, unless
otherwise noted. Propofol-induced vital sign changes from
baseline for the entire study cohort were compared using
student’s t-test and Wilcoxon nonparametric test, depending
on the distribution of the data, for continuous data and with
Fisher exact tests for categorical data. The two sedation groups
were compared with respect to demographic, clinical, and time
variables.Wealsoperformeda comparative subgroup analysis of
the patients who received low- and high-dose ketamine based
on their weight to assess if this was associated with any
signiﬁcant effect on the propofol dose and time variables among
the groups. Data were analyzed using dedicated statistical
software, SAS v9.3 (SAS Institute, Cary, NC). A p-value < 0.05
was considered statistically signiﬁcant. Data analysis was
performed by James E. Slaven, one of the authors of the manu-
script, who works for Indiana University’s School of Medicine’s
Department of Biostatistics.
Results
A total of 754 patients received procedural sedation for
painful procedures: 372 patients in the P-O group and 382
in the K þ P group. The most common procedures were
lumbar puncture, central line placement, dental procedures,
and bronchoscopies (►Table 1). There was no difference
between the groups with respect to age, weight, and gender
(►Table 2). Of the 754 procedures performed, 748 (99.2%)
were completed successfully with 18 patients (2.3%)
requiring adjunctivemedications. Seven patients in the K þ P
group required fentanyl, while in the P-O group eight
were given either fentanyl or midazolam to complete the
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procedure. Mean total dose of propofol was signiﬁcantly
different between groups (0.28  0.20 mg/kg/min for K þ P
vs. 0.40  0.26 mg/kg/min for P-O; p < 0.0001) (►Fig. 1).
Median procedure time was longer in the K þ P group with
shorter recovery times compared with the P-O group
(►Table 2 and ►Fig. 2). The incidence of adverse events
was comparable between the groups (16.5% for K þ P vs.
15.6% for P-O) (►Table 3).
The 382 patients in K þ P group were further divided into
two groups (K þ P 25 and K þ P 50) based on the ketamine
dose they received. There were 186 patients in K þ P 50
group and 196 in K þ P 25 group. Because their ketamine
dose was based on weight, K þ P 25 includes the section of
patients who were older and heavier than the patients in the
K þ P 50 group but there was no gender difference among
the groups. The propofol dose was signiﬁcantly different
among the groups (0.32  0.21 mg/kg/min for K þ P 50 vs.
0.28  0.19 mg/kg/min for K þ P25; p < 0.0001) . Median
procedure timewas longer by 8.27minutes in K þ P 50 group
(22.92  17 vs. 14.65  11.82; p < 0.0001). Similarly,
recovery time also was longer by 1.36 minutes in K þ P 50
groups (17.75  9.36 vs. 16.36  9.33; p < 0.001).
The incidence of adverse events was comparable between
the groups.
All the patients were NPO for 8 hours prior to
procedure and no one has hypersecretion or was given
prophylactic anticholinergic to prevent this. There was no
episode of aspiration in any of the patients. The most
common adverse event in both groups was desaturation,
and all of the patients responded to airway positioning or
supplemental oxygen. Five (1.3%) patients in the K þ P
group and three (0.8%) in the P-O group required bag-
valve-mask ventilation but no one in either group required
tracheal intubation.
Table 2 Demographics and times
Ketamine þ propofol (n ¼ 382) Propofol group (n ¼ 372) p-Value
Age (y) 7.3 (5.4) 7.3 (5.5) 0.99
Weight (kg) 30.1 (24.5) 30.1 (23.2) 0.81
Male (%) 216 (56.5%) 212 (57.0%) 0.90
Propofol dose (mg/kg/min) 0.28 (0.20) 0.40 (0.26) <0.0001
Procedure time (min) 18.68 (15.13) 15.11 (12.77) <0.01
Recovery time (min) 17.04 (9.36) 22.17 (12.84) <0.01
Overall time (min) 35.71 (17.46) 37.23 (17.88) 0.16
Note: Values are mean (standard deviation) for continuous variables and frequency (%) for categorical variables. p-Values are from Wilcoxon
nonparametric test, due to skewness in data, and Fisher exact test for categorical variables.
Table 1 Comparison of speciﬁc procedures
Ketamine þ propofol Propofol p-Value
Number Procedure time
in minutes
Number Procedure time
in minutes
Minor orthopedic procedures 10 14 (10) 7 12 (6) 0.845
Chest tubes 5 13 (5) 4 13 (12) 0.549
Bronchoscopies 39 12 (5) 46 10 (6) 0.038
Bone marrow 34 11 (6) 13 9 (6) 0.545
Lumbar punctures 113 10 (7) 113 10 (8) 0.843
Lumbar punctures þ bone marrow 15 16 (8) 14 11 (5) 0.049
Dental procedures 16 48 (13) 10 31 (15) 0.018
Central line insertions 40 28 (13) 46 21 (12) 0.011
Auditory brainstem responses 15 40 (18) 7 39 (20) 0.972
Kidney biopsies 15 13 (6) 10 12 (4) 0.642
Liver biopsies 8 14 (6) 14 9 (3) 0.055
Burn/wound dressing changes 16 27 (13) 12 18 (9) 0.040
Bone scan 12 44 (16) 13 45 (20) 0.957
CT scan 12 11 (5) 38 11 (7) 0.981
Other 32 26 (17) 24 21 (16) 0.202
Note: Values are the number of procedures and the mean (standard deviation) of procedure time in minutes. p-Values are from Wilcoxon
nonparametric tests due to the skewness of the data.
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Hypotension was deﬁned as one blood pressure recording
below the age-based normal range.5 The incidence of hypo-
tension between the groups was not statistically signiﬁcant
(p ¼ 0.56). Although a drop in blood pressure was commonly
observed, medical intervention was not needed.
Discussion
Many children require procedures for diagnosis and manage-
ment.14 Some procedures are brief but can be painful and
anxiety provoking. Children undergoing painful diagnostic
and therapeutic interventions in outpatient and inpatient
settings are routinely managed with sedatives. Amnesia and
analgesia with a predictable depth of sedation, a short
duration of action, and rapid, uneventful recovery are the
important aspects of ideal sedation regimen.
Propofol does exhibit numerous exceptionally desirable
characteristics as a procedural sedation agent. First of all, it
has an essentially immediate effect after IV administration. It
also has a marked potency of reliably producing effective
sedation even for very painful procedures at higher doses.
Propofol, itself, does not have analgesic properties. Further-
more, the recovery after sedation is exceptionally short,
typically 5 to 15 minutes. Finally, patient satisfaction is
high because propofol has amnesic and apparent euphoric
properties. No doubt this agent is very popular despite its
potential for respiratory depression and hypotension.10Many
studies have suggested that adding ketamine to propofol
might enhance hemodynamic stability, decrease respiratory
depression, stabilize respiratory drive, and add analgesia even
at small doses.11,15–20 In the dose range between 0.1 and 0.5
mg/kg, well below those used to induce dissociative sedation,
ketamine has well-documented analgesic effects. In our
study, we used higher doses for children <20 kg and lower
doses in children with > 20 kg to avoid the side effects of
emergence reaction and excessive salivation but still within
the range of dosage described in the literature to produce
adequate analgesia for procedural sedation.21–23
Peak level of sedationwas achieved almost immediately in
the P-O group and required up to 3 minutes in K þ P group.
This delay in onset of peak sedation in the K þ P group is
attributed to the waiting time required for ketamine to take
effect and to switch the syringes prior to propofol (►Fig. 3).
All procedures were completed comfortably with a failure
Fig. 1 Mean propofol dose.
Fig. 2 Procedure time, recovery time, and total time.
Table 3 Complications and adjunctive therapy
Complication or
adjunctive therapy
Ketamine þ
propofol
Propofol
only
p-Value
Desaturation 63 (16.5) 58 (15.7) 0.767
Bag-valve-mask
ventilation
5 (1.3) 3 (0.8) 0.725
Hypotension 16 (4.2) 12 (3.2) 0.565
Unable to complete
procedure
2 (0.5) 4 (1.0) 0.526
narcotic 7 (1.8) 6 (1.6) 1.000
Benzodiazepine 0 (0) 2 (0.5) 0.151
Ondansetron 3 (0.8) 17 (4.6) 0.001
Fig. 3 Time to peak sedation: values displayed are medians with
interquartile ranges.
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rate of only 0.8%. Seven in the K þ P and eight in the P-O
group required protocol deviation by adding either fentanyl/
versed. Like other studies, use of ketamine resulted in
statistically signiﬁcant decrease in the propofol dose
requir ment and resulted in rapid recovery in this group of
patients24 (►Fig. 3).
Bradycardia has been described as a possible adverse effect
of propofol when administered alone or in combination with
opioids.25,26 In our study, the incidence of bradycardia was
zero (deﬁned as a decrease in heart rate>20% from baseline).
Propofol has also been shown to cause transient decrease in
blood pressure when administered as a bolus or prolonged
infusion.25,26 No patient in this study experienced
hypotension (deﬁned as >20% decrease in blood pressure
from baseline) (►Table 3).
Respiratory events constitute a large proportion
(5.5–31.7%) of sedation complications in children.27,28 We
observed similar levels of hypoxemia (16% of patients). The
occurrence of apnea appears to depend on the dose and
the rate of administration, with a high incidence of apnea
reportedwith the larger doses. No one in our study had apneic
episodes.29,30 The majority of the patients simply required
airway positioning and use of supplemental oxygen. Poten-
tially, serious airway complications occurred in 1% of the
patients overall; all such events were quickly identiﬁed and
easily dealt with the use of brief bag-valve-mask ventilation
by the pediatric intensivist. In our study, the addition of
low-dose ketamine was not associated with any decrease
incidence of desaturation between the groups.
Of note, no prophylactic supplemental oxygen was adminis-
tered unless the oxygen saturation fell below 90%. This likely
contributed signiﬁcantly to the frequencyand rapidity of oxygen
desaturation. The use of routine supplemental oxygen adminis-
tration during procedural sedation of selected low-risk patients
is debatable.31 Published trials have not identiﬁed a standard-
ized approach to its use.1,32 It can be asserted that oxygen
desaturation in patients breathing room air is an early and
rapidly detected sign of respiratory depression, helping the
sedating physician to recognize an otherwise subtle event.
Additionally, room air desaturation typically responds quickly
to administration of oxygen,patient stimulation, or interruption
of propofol administration.
ETC02 was monitored throughout the procedure, yet the
recordingswere often unreliable asmost of the procedureswere
brief and in some procedures the oral cavity had to be main-
tainedwide openorwas beingmanipulated, thus decreasing the
value of continuous capnography as a monitoring tool for this
type of procedure. A previous study found that for low-risk
patients breathing room air, oxygen desaturation usually pre-
cedes changes in capnography during procedural sedation with
propofol and is readily reversible.33
No patient experienced nausea, vomiting, shivering, or
perspirationwith anyof the two groups. All the patients at the
time of discharge were given verbal and printed instruction
and provided with a 24-hour callback contact number if any
complication happened or any assistance was needed. No
emergence phenomenon was observed, which is not
surprising given our low-dose ketamine. In a previous study
using a medium dose of 0.75 mg/kg ketamine co-adminis-
tered with propofol, 3 of 114 patients experienced emergent
reaction and 1 required treatment.34
The time required for patients to reach full recovery could
be seen as a signiﬁcant beneﬁt. Patients in the K þ P group
reached their presedation level of consciousness prior to
patients in the P-O group within minutes of completion of
the procedure. It is also important to mention that mean
procedure time in the K þ P groupwas longer than P-O group
by 3 minutes; however, this is likely inﬂuenced by the
procedure itself rather than the procedural sedation
approach.
In the subgroup analysis of K þ P group, the interesting
ﬁnding was the need for a high propofol dose in patients with
high-dose ketamine. Even though the K þ P 50 group has
higher per kg ketamine dose, their cumulative dose was still
much lower than the K þ P 25 group due to signiﬁcant weight
difference among the groups (13.5  3.4 for K þ P 50 vs.
46  25 for K þ P 25; p < 0.01). This is the best explanation
that could be given for a high propofol dose requirement in
K þ P 50 group. The longer procedure time in K þ P5 0 group
is due to higher numbers of noninvasive procedures (35 vs. 4).
These noninvasive proceduresmostly include auditory brain-
stem responses and bone scans, and the average time for each
of this procedure is 40 to 50 minutes. The recovery time was
only slightly longer in K þ P 50 groups and did reach to a
statistically signiﬁcant difference but may not be of signiﬁ-
cant clinical effect.
The limitations of our study include its retrospective
nature and single-center experience. The current study
presents a 99% success rate of sedation for procedures using
either approach. It could be asserted that the reported
efﬁcacy is due to the use of an intensivist-based specialized
sedation team rather than to the medicines itself. This is
reasonably true to some extent as specialization and experi-
ence should increase both success and efﬁciency. In spite of
that, this can be statedwith conﬁdence: much of the reported
success is speciﬁcally a function of the drug used alone or in
combination. This is a descriptive study and few, if any,
conclusions can be drawn about safety. Addressing safety is
more of a secondary issue because the occurrence of serious
sedation-related side effects is, fortunately, rare.35 Additional
prospective studies of the procedural sedation using propofol
only versus propofol þ ketamine in a greater number of
pediatric patients are warranted to provide a true idea of
safety. Postoperative nausea and vomiting may occur with 24
hours of sedation or anesthesia. This side effect, even if to be
expected a rare one, may be underreported because of short
follow-up.
Conclusion
In conclusion, both the propofol-only approach and one that
includes a single initial low dose of I/V ketamine proved to be
well tolerated and equally effective for procedural sedation.
Addition of ketamine was associated with reduction in recovery
times, probably explained by the decrease in the propofol dose.
Both appear to be viable options for procedural sedation.
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